Effect of the increase in valve area after aortic valve replacement with a 19-mm aortic valve prosthesis on left ventricular mass regression in patients with pure aortic stenosis

Journal of Cardiovascular Medicine

Volumn 7, Issue 5, 2006, Pages 351-355

  Mhagna, Zen ^a   Tasca, Giordano ^a,b   Brunelli, Federico ^a   Cirillo, Marco ^a   Amaducci, Andrea ^a   DallaTomba, Margherita ^a   Troise, Giovanni ^a  

^a Poliambulanza Hospital   (Italy)

^b Unità Funzionale di Cardiochirurgia   (Italy)

Author keywords

Aortic valve; Prosthesis

Indexed keywords

ADULT; AGED; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; AORTIC VALVE STENOSIS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LINEAR MODELS; MALE; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; RESEARCH DESIGN; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 33746592972     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/01.JCM.0000223258.47180.9d     Document Type: Article

References (35)

1. Pibarot P, Dumesnil JG. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol 2000; 36:1131-1141.
2. Muneretto C, Bisleri G, Negri A, Manfredi J. The concept of patient-prosthesis mismatch. J Heart Valve Dis 2004; 13 (Suppl 1):S59-S62.
3. Rahimtoola SH. The problem of valve prosthesis-patient mismatch. Circulation 1978; 58:20-24.
4. Dumesnil JG, Honos GN, Lemieux M, Beauchemin J. Validation and applications of indexed aortic prosthetic valve areas calculated by Doppler echocardiography. J Am Coll Cardiol 1990; 16:637-643.
5. Del Rizzo DF, Abdoh A, Cartier P, Doty D, Westaby S. Factors affecting left ventricular mass regression after aortic valve replacement with stentless valves. Semin Thorac Cardiovasc Surg 1999; 11 (Suppl 1):114-120.
6. Tasca G, Brunelli F, Cirillo M, Dalla Tomba M, Mhagna Z, Troise G, Quaini E. Impact of valve prosthesis-patient mismatch on left ventricular mass regression following aortic valve replacement. Ann Thorac Surg 2005; 79:505-510.
7. Freed DH, Tam JW, Moon MC, Harding GEJ, Ahmad E, Pascoe EA. Nineteen-millimeter prosthetic aortic valves allow normalization of left ventricular mass in elderly women. Ann Thorac Surg 2002; 74:2022-2025.
8. Dumesnil JG, Yoganathan AP. Valve prosthesis hemodynamics and the problem of high transprosthetic pressure gradients. Eur J Cardiothorac Surg 1992; 6 (Suppl 1):S34-S38.
9. Tasca G, Brunelli F, Cirillo M, Dalla Tomba M, Mhagna Z, Troise G, Quaini E. Impact of the improvement of valve area achieved with aortic valve replacement on the regression of left ventricular hypertrophy in patients with pure aortic stenosis. Ann Thorac Surg 2005; 79:1291-1296.
10. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
11. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison with necropsy findings. Am J Cardiol 1986; 57:450-458.
12. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59:956-960.
13. Tasca G, Brunelli F, Cirillo M, Amaducci A, Mhagna Z, Troise G, Quaini E. Mass regression in aortic stenosis after valve replacement with small size pericardial bioprosthesis. Ann Thorac Surg 2003; 76:1107-1113.
14. Lund O, Emmertsen K, Dorup I, Jensen FT, Flo C. Regression of left ventricular hypertrophy during 10 years after valve replacement for aortic stenosis is related to the preoperative risk profile. Eur Heart J 2003; 24:1437-1446.
15. Carrier M, Pellerin M, Perrault LP, Hebert Y, Page P, Cartier R, et al. Experience with the 19-mm Carpentier-Edwards pericardial bioprosthesis in the elderly. Ann Thorac Surg 2001; 71 (Suppl):S249-S252.
16. Lund O, Kristensen LH, Baandrup U, Hansen OK, Nielsen TT, Emmertsen K, et al. Myocardial structure as a determinant of pre- and postoperative ventricular function and long-term prognosis after valve replacement for aortic stenosis. Eur Heart J 1998; 19:1099-1108.
17. Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003; 107:984-991.
18. Lund O, Larsen KE. Cardiac pathology after isolated valve replacement for aortic stenosis in relation to preoperative patient status. Early and late autopsy findings. Scand J Thorac Cardiovasc Surg 1989; 23:263-270.
19. Dellgren G, Eriksson MJ, Blange I, Brodin LA, Radegran K, Sylven C. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis. Am J Cardiol 1999; 84:909-913.
20. Garner C, Lecomte E, Visvikis S, Abergel E, Lathrop M, Soubrier F. Genetic and environmental influences on left ventricular mass. A family study. Hypertension 2000; 36:740-746.
21. Verdecchia P, Reboldi GP, Schillaci G, Borgioni C, Ciucci A, Telera MP, et al. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999; 100:1802-1807.
22. Imanaka K, Kohmoto O, Nishimura S, Yokote Y, Kyo S. Impact of postoperative blood pressure control on regression of left ventricular mass following valve replacement for aortic stenosis. Eur J Cardiothorac Surg 2005; 27:994-999.
23. Gelsomino S, Frassani R, Morocutti G, Porreca L, Tursi V, Masullo G, et al. Left ventricular mass regression after aortic valve replacement with CryoLife-O'Brien stentless aortic bioprosthesis. J Heart Valve Dis 2001; 10:603-610.
24. Jin XY, Pillai R, Westaby S. Medium-term determinants of left ventricular mass index after stentless aortic valve replacement. Ann Thorac Surg 1999; 67:411-416.
25. Gaudino M, Glieca F, Luciani N, Cellini C, Morelli M, Girola F, et al. Left ventricular mass regression after aortic valve replacement for aortic stenosis: time course and determinants. J Heart Valve Dis 2004; 13 (Suppl 1):S55-S58.
26. Pons-Llado G, Ballester M, Borras X, Carreras F, Carrio I, Lopez-Contreras J, et al. Myocardial cell damage in human hypertension. J Am Coll Cardiol 2000; 36:2198-2203.
27. Muiesan ML, Rizzoni D, Salvetti M, Monteduro C, Skeiman I, De Ciuceis C, et al. Left ventricular mass and function are related to collagen turnover markers in essential hypertension [abstract]. Am J Hypertens 2003; 16:895.
28. Lund O, Erlandsen M, Dorup I, Emmertsen K, Flo C, Jensen FT. Predictable changes in left ventricular mass and function during ten years after valve replacement for aortic stenosis. J Heart Valve Dis 2004; 13:357-368.
29. Briand M, Dumesnil JG, Kadem L, Tongue AG, Rieu R, Garcia D, Pibarot P. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol 2005; 46:291-298.
30. Pibarot P, Dumesnil JG, Jobin J, Cartier P, Honos G, Durand LG. Hemodynamic and physical performance during maximal exercise in patients with an aortic bioprosthetic valve: comparison of stentless versus stented bioprostheses. J Am Coll Cardiol 1999; 34:1609-1617.
31. Bach DS, Goldman B, Verrier E, Petracek M, Wood J, Goldman S. David T, for the Toronto SPV Valve Study Group. Impact of small valve size on hemodynamics and left ventricular mass regression with the Toronto SPV stentless aortic bioprosthesis. J Heart Valve Dis 2002; 11:236-241.
32. Rajappan K, Rimoldi OE, Camici PG, Bellenger NG, Pennell DJ, Sheridan DJ. Factors influencing alterations in coronary microcirculatory function in patients with aortic stenosis after aortic valve replacement. Circulation 2003; 107:3170-3175.
33. Monrad ES, Hess OM, Murakami T, Nonogi H, Corin WJ, Krayenbuehl HP. Time course of regression of left ventricular hypertrophy after aortic valve replacement. Circulation 1988; 77:1345-1355.
34. Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989; 79:744-755.
35. Kurnik PB, Innerfield M, Wachspress JD, Eldredge WJ, Waxman HL. Left ventricular mass regression after aortic valve replacement measured by ultrafast computed tomography. Am Heart J 1990; 120:919-927.